[Current therapy: immunopharmaceuticals].
Immunopharmarca are classified as follows: thymus factors and hormones, lymphokines and cytokines, microbial products, drugs with potential effects on the immune system, and external immunomodulators. We discuss new drugs and substances such as Timunox, Tp-1 Serono, delimmun, Isoprenosine, recombinant interleukin 2, Immuneron, tumor necrosis factor, Sandimmun, and diphencyprone, as well as drugs already known like Levamisole, Bestatin, gold, sulfones, and sulfopyridines.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D016207:Cytokines; D003622:Dapsone / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods*; D007930:Leucine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008222:Lymphokines / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001688:Biological Products; D003524:Cyclosporins; D016207:Cytokines; D007166:Immunosuppressive Agents; D008222:Lymphokines; D013951:Thymus Hormones; D012460:Sulfasalazine; D006046:Gold; D003622:Dapsone; D007930:Leucine; C012211:ubenimex
Aktuelle Therapie: Immunopharmaka.